The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
Open accessAbstract
Extensive research causally links amyloid-beta peptide (A beta) to Alzheimer's disease, although the pathologically relevant A beta conformation remains unclear. A beta spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A beta. To consistently prepare in vitro oligomeric and fibrillar forms of A beta 1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A beta species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta 1-42-induced neurotoxicity significant at 10 nm. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A beta1-42 from isoforms containing familial mutations (Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) J. Biol. Chem. 277, 32046-32053). Understanding the biological role of specific A beta conformations may define the link between A beta and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A beta ultimately responsible for the cognitive dysfunction that defines the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Flagged first, then by citations
Research works printed but not linked: 3
- Hou, 2002, J. Biol. Chem., 26, 26
- DePace, 2002, Nat. Struct. Biol., 9, 389
- Fezoui, 2002, J. Biol. Chem., 30, 30
Cited by
Sorted by citations
Items 601–700 of 999
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications
Gregori, M., Cassina, V., Brogioli, D., Salerno, D., Kimpe, L. D., Scheper, W., Masserini, M., & Mantegazza, F. (2010) · European Biophysics Journal · doi:10.1007/s00249-010-0619-6 · Cited by 20
Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
Park, S.-K., Ratia, K. M., Ba, M. A., Valencik, M. L., & Liebman, S. W. (2016) · Microbial Cell · doi:10.15698/mic2016.02.476 · Cited by 21
Fu, L., Li, Y., Hu, Y., Zheng, Y., Yu, B., Zhang, H., Wu, J., Wu, H., Yu, X., & Kong, W. (2017) · Scientific Reports · doi:10.1038/srep41041 · Cited by 20
Chun, Y. S., Kim, J., Chung, S., Khorombi, E., Naidoo, D., Nthambeleni, R., Harding, N., Maharaj, V. J., Fouché, G., & Yang, H. O. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04451 · Cited by 20
Mantle, J. L., & Lee, K. H. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26967 · Cited by 20
Kinetic Transition in Amyloid Assembly as a Screening Assay for Oligomer-Selective Dyes
Barton, J., Arias, D. S., Niyangoda, C., Borjas, G. J., Le, N., Mohamed, S., & Muschol, M. (2019) · Biomolecules · doi:10.3390/biom9100539 · Cited by 20
Haptoglobin Modulates Beta-Amyloid Uptake by U-87 MG Astrocyte Cell Line
Maresca, B., Spagnuolo, M. S., & Cigliano, L. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0465-6 · Cited by 20
Granular Non-Fibrillar Aggregates and Toxicity in Alzheimer’s Disease
Benseny‐Cases, N., Klementieva, O. L., Malý, J., & Cladera, J. (2012) · Current Alzheimer Research · doi:10.2174/156720512803251129 · Cited by 19
D’Oliveira Albanus, R., Finan, G. M., Brase, L., Sweeney, N., Kim, T. Y., Chen, S., Ryoo, Y., Park, J., Guo, Q., Iyer, A. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adx0027 · Cited by 19
Anzovino, A., Canepa, E., Alves, M., Lemon, N. L., Carare, R. O., & Fossati, S. (2023) · Cells · doi:10.3390/cells12242840 · Cited by 19
Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions
Cieplak, A. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180905 · Cited by 21
Pachahara, S. K., & Nagaraj, R. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.04.005 · Cited by 19
Ajit, D., Udan, M. L. D., Paranjape, G. S., & Nichols, M. R. (2009) · Biochemistry · doi:10.1021/bi9003777 · Cited by 18
Dias, L., Madeira, D., Dias, R., Tomé, Â. R., Cunha, R. A., & Agostinho, P. M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04492-y · Cited by 19
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics
Arar, S. H., Haque, M. A., & Kayed, R. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26561 · Cited by 20
Simple model for the simulation of peptide folding and aggregation with different sequences
Enciso, M., & Rey, A. (2012) · The Journal of Chemical Physics · doi:10.1063/1.4725883 · Cited by 18
Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins
Papaleo, E., & Invernizzi, G. (2010) · Current Computer - Aided Drug Design · doi:10.2174/157340911793743574 · Cited by 18
Salza, R., Lethias, C., & Ricard‐Blum, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160751 · Cited by 18
Muñoz, Y., Paula-Lima, A. C., & Núñez, M. T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.006 · Cited by 21
Wesén, E. V., Gallud, A., Paul, A., Lindberg, D. J., Malmberg, P., & Esbjörner, E. K. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.08.010 · Cited by 20
Bao, Y., Yang, X., Fu, Y., Zhengyan, L., Gong, R., & Lü, W. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00260-3 · Cited by 18
Role of phosphatidylserine in amyloid-beta oligomerization at asymmetric phospholipid bilayers
Robinson, J., Sarangi, N. K., & Keyes, T. E. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp03344e · Cited by 18
Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer’s Disease Pathology
Tannenberg, R. K., Shamaileh, H. A., Lauridsen, L. H., Kanwar, J. R., Dodd, P. R., & Veedu, R. N. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040009 · Cited by 17
Interaction of a β‐sheet breaker peptide with lipid membranes
Vitiello, G., Grimaldi, M., Ramunno, A., Ortona, O., Martino, G., D’Ursi, A. M., & D’Errico, G. (2010) · Journal of Peptide Science · doi:10.1002/psc.1207 · Cited by 18
VandeVrede, L. A., Tavassoli, E., Luo, J., Qin, Z., Lan, Y., Pepperberg, D. R., & Thatcher, G. R. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12454 · Cited by 19
Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC
Wang, Y., Zhou, T. H., Zhi, Z., Barakat, A., Hlatky, L., & Querfurth, H. W. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00129 · Cited by 20
Caballero, E., Calvo-Rodríguez, M., Gonzalo‐Ruiz, A., Villalobos, C., & Núñez, L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.041 · Cited by 20
Kim, S., Lee, E.-H., Lee, S., Kim, A.-R., Park, H., Son, J., Koh, S., & Yoon, M. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113921 · Cited by 18
Hierarchy and the mechanism of fibril formation in ADan peptides
Surolia, I., Reddy, G. B., & Sinha, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04072.x · Cited by 18
Choi, I., Lee, E., Song, M., & Lee, L. P. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.11.2344 · Cited by 17
Cha, W., Heo, C., Lee, S., Yun, S. J., Cho, B. W., Ha, T., & Lee, Y. H. (2023) · ACS Nano · doi:10.1021/acsnano.2c11428 · Cited by 17
Probing differences among Aβ oligomers with two triangular trimers derived from Aβ
Kreutzer, A. G., Guaglianone, G., Yoo, S., Parrocha, C. M. T., Ruttenberg, S. M., Malonis, R. J., Tong, K., Lin, Y.-F., Nguyen, J. T., Howitz, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219216120 · Cited by 18
Chuang, W.-H., Chou, Y.-T., Chen, Y.-H., Kuo, T.-H., Liaw, W., Lu, T., Kao, C.-F., & Wang, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00348 · Cited by 17
Xiao, Q., Wang, J., Tian, Q., Tian, N., Tian, Q., He, X., Wang, Y., & Dong, Z. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03818-6 · Cited by 18
Kwon, H., Crisostomo, A. C., Smalls, H. M., & Finke, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120420 · Cited by 17
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17
Adem, K. A., Shanti, A., Srivastava, A., Homouz, D., Thomas, S. A., Khair, M., Stefanini, C., Chan, V., Kim, T., & Lee, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.842582 · Cited by 17
Bellingacci, L., Tallarico, M., Mancini, A., Megaro, A., Caro, C. D., Citraro, R., Sarro, G. D., Tozzi, A., Filippo, M. D., Sciaccaluga, M., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109373 · Cited by 17
The study of Alzheimer’s disease biomarkers
Vestergaard, M. C. M., Kerman, K., & Tamiya, E. (2006) · Nanobiotechnology · doi:10.1007/s12030-006-0002-y · Cited by 17
Detection and reduction of microaggregates in insulin preparations
Heldt, C. L., Sorci, M., Posada, D., Hirsa, A. H., & Belfort, G. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22902 · Cited by 17
Shigemitsu, Y., Iwaya, N., Goda, N., Matsuzaki, M., Tenno, T., Narita, A., Hoshi, M. M., & Hiroaki, H. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2015.12.021 · Cited by 17
Terrill, S. E., Colvin, B. A., Davenport, R. E., & Nichols, M. R. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.03.017 · Cited by 18
Enlargement of Aβ aggregates through chemokine-dependent microglial clustering
Huang, W.-C., Yen, F.-C., Shiao, Y., Shie, F., Chan, J.-L., Yang, C.-N., Sung, Y.-J., Huang, F.-L., & Tsay, H.-J. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.01.001 · Cited by 18
Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics
Bosc, E., Anastasie, J., Soualmia, F., Coric, P., Kim, J. Y., Wang, L. Q., Lacin, G., Zhao, K., Patel, R., Duplus, E., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05396-2 · Cited by 16
Satarker, S., Gurram, P. C., Nassar, A., Manandhar, S., Vibhavari, R. J. A., Yarlagadda, D. L., Mudgal, J., Lewis, S. A., Arora, D. S., & Nampoothiri, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03844-4 · Cited by 16
Uzoechi, S. C., Collins, B., Badeaux, C. J., Li, Y., Kwak, S. S., Kim, D. Y., Laskowitz, D. T., Lee, J., & Yun, Y. (2024) · Applied Sciences · doi:10.3390/app14093917 · Cited by 16
Li, G., Klein, J., & Zimmermann, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.040 · Cited by 16
Morphology‐Specific Inhibition of β‐Amyloid Aggregates by 17β‐Hydroxysteroid Dehydrogenase Type 10
Aitken, L., Quinn, S. D., Pérez‐González, C., Samuel, I. D. W., Penedo, J. C., & Gunn‐Moore, F. J. (2016) · ChemBioChem · doi:10.1002/cbic.201600081 · Cited by 16
Ghura, S., Tai, L. M., Zhao, M., Collins, N., Che, C., Warpeha, K. M., & LaDu, M. J. (2016) · Scientific Reports · doi:10.1038/srep29364 · Cited by 17
Self-citationYang, E.-J., Kim, H.-J., Kim, H.-S., & Chang, M. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.01.008 · Cited by 16
Amyloid-β25-35 Induces Apolipoprotein D Synthesis and Growth Arrest in HT22 Hippocampal Cells
Martínez‐Pinilla, E., Navarro, A., Ordóñez, C., del Valle, E., & Tolivia, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112102 · Cited by 16
Patel, A., Vasanthan, V., Fu, W., Fahlman, R. P., MacTavish, D., & Jhamandas, J. H. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1007-x · Cited by 19
Up-regulation of calsyntenin-3 by β-amyloid increases vulnerability of cortical neurons
Uchida, Y., Nakano, S.-I., Gomi, F., & Takahashi, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.025 · Cited by 16
Bateman, D. A., & Chakrabartty, A. (2004) · Biopolymers · doi:10.1002/bip.10561 · Cited by 16
Gao, F., Hou, Y., Wang, Y., Liu, L., Yi, X., & Xia, N. (2025) · Biosensors · doi:10.3390/bios15080480 · Cited by 15
Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease
Boskovic, P., Shalita, R., Gao, W., Vernon, H., Deng, Y. L., Colonna, M., Majzner, R. G., Amit, I., & Kipnis, J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2530977123 · Cited by 16
Critical aggregation concentration and reversibility of amyloid-β (1–40) oligomers
Illodo, S., Al‐Soufi, W., & Novo, M. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110179 · Cited by 16
de la Fuente, E., Adura, C., Kogan, M. J., & Bollo, S. (2012) · Electroanalysis · doi:10.1002/elan.201100607 · Cited by 15
Ning, L., Guo, J., Bai, Q., Jin, N., Liu, H., & Yao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087266 · Cited by 15
The Nuclear Inclusion a (NIa) Protease of Turnip Mosaic Virus (TuMV) Cleaves Amyloid-β
Han, H.-E., Sellamuthu, S., Shin, B. H., Lee, Y., Song, S., Seo, J.-S., Baek, I., Bae, J., Kim, H., Yoo, Y. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015645 · Cited by 15
Hoogerhout, P., Kamphuis, W., Brugghe, H. F., Sluijs, J. A., Timmermans, H., Westdijk, J., Zomer, G., Boog, C. J. P., Hol, E. M., & van den Dobbelsteen, G. P. J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019110 · Cited by 15
Karelina, T., Demin, O. O., Demin, O. O., Duvvuri, S., & Nicholas, T. (2017) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12249 · Cited by 15
Walker, A., Raliski, B. K., Karbasi, K., Zhang, P., Sanders, K., & Miller, E. W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.643859 · Cited by 16
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01070-5 · Cited by 15
Pathology of Neurodegenerative Diseases
Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 16
Fine Mapping of the Amyloid β-Protein Binding Site on Myelin Basic Protein
Kotarba, A. E., Aucoin, D., Hoos, M. D., Smith, S. O., & Nostrand, W. E. V. (2013) · Biochemistry · doi:10.1021/bi4001936 · Cited by 15
Watanabe, K., Ishikawa, C., Kuwahara, H., Sato, K., Komuro, S., Nakagawa, T., Nomura, N., Watanabe, S., & Yabuki, M. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5648-1 · Cited by 15
Facile Methodology for Monitoring Amyloid-β Fibrillization
Cook, N. P., & Martí, A. A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300135n · Cited by 17
Kim, H. Y., Lee, D., Ryu, K., & Choi, I. (2017) · Chemical Communications · doi:10.1039/c7cc00358g · Cited by 15
Todd, K. L., Fossati, S., Ghiso, J. A., & Rostagno, A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.010 · Cited by 15
Oligomeric amyloid-β(1–42) induces THP-1 human monocyte adhesion and maturation
Crouse, N. R., Ajit, D., Udan, M. L. D., & Nichols, M. R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.093 · Cited by 17
Pilat, D. J., Le, H., Prokopenko, D., Lin, C.-C. J., Eimer, W. A., Quinti, L., Gavrilles, E. P., Garcia, S. N., Heitman, S. N., McGinty, D., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.09.032 · Cited by 14
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease
Zhou, C., Zeng, F., Yang, H., Liang, Z., Xu, G., Li, X., Liu, X., & Yang, J. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06690-1 · Cited by 14
Piccialli, I., Tedeschi, V., Boscia, F., Ciccone, R., Casamassa, A., de Rosa, V., Grieco, P., Secondo, A., & Pannaccione, A. (2020) · Toxins · doi:10.3390/toxins13010020 · Cited by 14
A Solvatochromic Near Infrared Fluorophore Sensitive to the Full Amyloid Beta Aggregation Pathway
Wang, Z., Kristensen, L. G., Ho, Y. H., Liu, Y., Valencia, L. A., Nadig, I., Range, K. L., Rad, B., Ralston, C. Y., & Cohen, B. E. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01512 · Cited by 14
Anchored FRET sensors detect local caspase activation prior to neuronal degeneration
Figueroa, R. A., Ramberg, V., Gatsinzi, T., Samuelsson, M., Zhang, M., Iverfeldt, K., & Hallberg, E. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-35 · Cited by 14
The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
Porter, T., Bharadwaj, P., Groth, D., Paxman, A., Laws, S. M., Martins, R. N., & Verdile, G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150790 · Cited by 14
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
Marcello, E. E., Musardo, S., Vandermeulen, L., Pelucchi, S., Gardoni, F., Santo, N., Antonucci, F., & Luca, M. D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1583-5 · Cited by 14
Jäkel, L., Biemans, E. A. L. M., Klijn, C. J. M., Kuiperij, H. B., & Verbeek, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01873-x · Cited by 15
Rojas-Charry, L., Calero-Martinez, S. A., Morganti, C., Morciano, G., Park, K., Hagel, C., Marciniak, S. J., Glatzel, M., Pinton, P., & Falla, D. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63254-7 · Cited by 14
Lipid membranes induce structural conversion from amyloid oligomers to fibrils
Gu, L., & Guo, Z. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.174 · Cited by 14
Olajide, O. J., & Chapman, C. A. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.006 · Cited by 14
c-Jun Regulates the Stability of Anti-Apoptotic ΔNp63 in Amyloid-β-Induced Apoptosis
Fonseca, M. B., Nunes, A. F., & Rodrigues, C. M. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111547 · Cited by 14
Application of Photochemical Cross-linking to the Study of Oligomerization of Amyloidogenic Proteins
Lopes, D. H. J., Sinha, S., Rosensweig, C., & Bitan, G. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_2 · Cited by 14
Nardo, L., Re, F., Brioschi, S., Cazzaniga, E., Orlando, A., Minniti, S., Lamperti, M., Gregori, M., Cassina, V., Brogioli, D., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.003 · Cited by 14
Ciccone, R., Piccialli, I., Grieco, P., Merlino, F., Annunziato, L., & Pannaccione, A. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00479 · Cited by 14
Dorsey, M. P., Nguelifack, B. M., & Yates, E. A. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00694 · Cited by 14
Adsorption of Amyloid β (1-40) Peptide at Liquid Interfaces
Brezesinski, G., Maltseva, E., & Möhwald, H. (2006) · Zeitschrift für Physikalische Chemie · doi:10.1524/zpch.2007.221.1.95 · Cited by 14
Tanaka, K., Nishimura, M., Yamaguchi, Y., Hashiguchi, S., Takiguchi, S., Yamaguchi, M., Tahara, H., Gotanda, T., Abe, R., Ito, Y., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.010 · Cited by 14
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseases
Won, W., Lee, E. H., Gotina, L., Chun, H., Lee, J., Bhalla, M., Park, U., Kim, D., Kim, T. Y., Choi, J. W., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02366-w · Cited by 16
Zubillaga, M., Abadin, X., Ivars, E., Puigròs, M., Trullás, R., Bellini, M. J., Arnal, N., & Colell, A. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103872 · Cited by 17
Cheng, T., Yuan, H., Dong, Y., Xu, S., Wang, G., Zhao, M., Jiao, J., & Jiao, J. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01502e · Cited by 13
Saraiva, A. M., Pereira, M. D. C., & Brezesinski, G. (2010) · Langmuir · doi:10.1021/la101203h · Cited by 13
Kato, D., Takahashi, Y., Iwata, H., Hatakawa, Y., Lee, S. H., & Oe, T. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101268 · Cited by 13
Rogers, E. A., Beauclair, T., Martinez, J., Mufti, S. J., Kim, D., Sun, S., Stingel, R. L., Dieterly, A. M., Krishnan, N., Crodian, J. S., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00248a · Cited by 13
Saini, R., Navale, G. R., Singh, S., Singh, H. K., Chauhan, R., Agrawal, S., Sarkar, D. M., Sarma, M., & Ghosh, K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125847 · Cited by 13
Yang, X., Huang, H., Chen, L., Xu, W. X., & Jiang, Z.-F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1186 · Cited by 13
Time resolved structure analysis of growing β-amyloid fibers
WITTE, T., Haller, L. A., Luttmann, E., Krüger, J., Fels, G., & Huber, K. P. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.02.006 · Cited by 13
A new class of aggregation inhibitor of amyloid-β peptide based on an O-acyl isopeptide
Kawashima, H., Sohma, Y., Nakanishi, T., Kitamura, H., Mukai, H., Yamashita, M., Akaji, K., & Kiso, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.062 · Cited by 13
Lukiw, W. J., Bjattacharjee, S., Zhao, Y., Pogue, A. I., & Percy, M. E. (2012) · PubMed · doi:10.4172/2161-0460.s2-0011 · Cited by 13
Metadata
- Authors
- Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- ORCID
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11612-11622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133631618
- Cited by
- 1,015
- References
- 74
- Citations by year
- 2026: 40 · 2025: 39 · 2024: 37 · 2023: 39 · 2022: 34 · 2021: 49 · 2020: 37 · 2019: 40 · 2018: 33 · 2017: 46 · 2016: 49 · 2015: 42 · 2014: 60 · 2013: 52 · 2012: 69
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Northwestern University
- National Institutes of Health (1p01ag015501-01, 5r01ag013496-05)
- National Institute on Aging (R01AG019121, AG-15501, AG 19121, AG13496)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta 42, oligomerization, fibril formation, Alzheimer's disease, neurotoxicity, peptide aggregation, solution conditions, familial Alzheimer's disease mutations, amyloid plaques, peptide conformation
- MeSH terms
- Biopolymers, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Peptide Fragments, Solubility, Blotting, Western, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review